PRognostic factor of Early Death In phase II Trials or the end of ‘sufficient life expectancy’ as an inclusion criterion? (PREDIT model)

Overview of attention for article published in BMC Cancer, October 2016

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 1,548 followers.

PRognostic factor of Early Death In phase II Trials or the end of ‘sufficient life expectancy’ as an ... https://t.co/2gcaCRsDvr #cancer

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.